1-hexadecyl-2-acetyl-glycero-3-phosphocholine and alprostadil

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with alprostadil in 51 studies

Compound Research Comparison

Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Studies (alprostadil)	Trials (alprostadil)	Recent Studies (post-2010) (alprostadil)
9,156	187	552	7,136	864	761

Protein Interaction Comparison

Protein	Taxonomy	1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50)	alprostadil (IC50)
Multidrug resistance-associated protein 4	Homo sapiens (human)		2.3
Solute carrier organic anion transporter family member 2B1	Rattus norvegicus (Norway rat)		0.0358

Research

Studies (51)

Timeframe	Studies, this research(%)	All Research%
pre-1990	31 (60.78)	18.7374
1990's	16 (31.37)	18.2507
2000's	3 (5.88)	29.6817
2010's	1 (1.96)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bochkov, VN; Fuki, IV; Lyakishev, AA; Matchin, YG; Tkachuk, VA	1
Braun, M; Bruch, L; Ney, P; Schrör, K; Szymanski, C	1
Ichikawa, Y; Kawada, N; Kobayashi, K; Mizoguchi, Y; Morisawa, S	1
García-Sáinz, JA; Gutiérrez-Venegas, G	1
Hsueh, W; Zhang, C	1
Chambaut-Guerin, AM; Delbourg, I; Ribier, A; Thomopoulos, P; Ventura, MA	1
Haslam, RJ; Maurice, DH	1
Inagaki, N; Koda, A; Miura, T; Nagai, H; Ohira, K; Xu, QA	1
Avdonin, PV; Boogry, EM; Cheglakov, IB; Mazaev, AV; Svitina-Ulitina, IV; Tkachuk, VA	1
Hecker, G; König, E; Ney, P; Schrör, K	1
Lefer, AM; Stahl, GL; Terashita, Z	2
Hecker, G; Ney, P; Schröder, H; Schrör, K	1
Bekemeier, H; Sänze, JU	1
Faustman, EM; Geissler, FT; Henderson, WR; Kuzan, FB	1
Ershov, DE; Fedorov, NA; Tatarintsev, AV; Varfolomeev, SD; Vrzheshch, PV; Zaĭtsev, SV	1
Burde, R; Schultz, G; Seifert, R	1
Hoffmann, IH; Mentz, G; Mentz, P; Mest, HJ; Meyer, E; Riedel, A; Sperling, J; Tschorn, W	1
Di Marzo, V; Morris, HR; Tippins, JR	1
Benveniste, J; Bourdillat, B; Brink, C; Delautier, D; Labat, C; Potier, P	1
Ng, DS; Wong, K	1
Bühler, FR; Dimitrov, D; Resink, TJ; Stucki, S	1
Esumi, N; Hashida, T; Imashuku, S; Nakajima, F; Todo, S; Tsunamoto, K	1
Butcher, RW; Clark, RB; Proll, MA	1
Avdonin, PV; Men'shikov, MIu; Orlov, SN; Pokudin, NI; Tkachuk, VA	1
Arroyave, JL; Gonzalez-Crussi, F; Hsueh, W	1
Dierichs, R; Patscheke, H	1
Banner, B; Chapchap, P; Esquivel, CO; Makowka, L; Mazzaferro, V; Miller, C; Pan, C; Podesta, L; Pressley, D; Todo, S	1
Rampart, M; Williams, TJ	1
Lapetina, EG; Siess, W	1
Ma, YH; Ouyang, CH; Teng, CM	1
Andries, R; Bourgain, RH; Braquet, M; Braquet, P; Maes, L; Touqui, L	1
Bergelson, LD; Kulikov, VI; Muzia, GI	1
Haslam, RJ; Vanderwel, M	1
Hillmar, I; Muramatsu, T; Zöllner, N	1
Inada, Y; Nishikawa, K; Nomura, H; Terashita, Z; Tsushima, S; Yoshioka, Y	1
Barth, T; Bekemeier, H; Hänsel, F; Hirschelmann, R; Sänze, JU	1
Bergel'son, LD; Kulikov, VI; Muzia, GI	1
Morley, J; Page, CP; Paul, W	1
Hellewell, PG; Teixeira, MM; Williams, TJ	1
Ahluwalia, A; Perretti, M	1
Jørgensen, L; Kinlough-Rathbone, RL; Mustard, JF; Nilsen, GJ; Perry, DW	1
Alvarez, R; Kaneko, T; Nadel, JA; Ueki, IF	1
Fang, GD; Guerrant, RL; Marcinkiewicz, M; Sarosiek, J; Thielman, NM	1
al-Rashed, S; Hellewell, PG; Rossi, AG; Teixeira, MM	1
Kulikov, VI; Muzya, GI	2
Chambers, EL; Downing, SJ; Leese, HJ; Maguiness, SD; Watson, A	1
Keown, PA; Nikbakht-Sangari, M; Qayumi, AK	1
Afanasjeva, G; Avdonin, P; Baskova, I; Berezhnoy, S; Gabbasov, Z; Popov, E; Zavalova, L	1
Fox, SC; Glenn, JR; Heptinstall, S; Iyú, D; Johnson, A; White, AE	1

Other Studies

51 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and alprostadil

Article	Year
Platelets in patients with homozygous familial hypercholesterolemia are sensitive to Ca(2+)-mobilizing activity of low density lipoproteins. Atherosclerosis, 1992, Volume: 96, Issue:2-3 Topics: Adenosine Diphosphate; Adolescent; Adult; Alprostadil; Blood Platelets; Calcium; Child; Cytoplasm; Epinephrine; Female; Homozygote; Humans; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Male; Platelet Activating Factor; Receptors, Cell Surface; Receptors, Lipoprotein	1992
Antiplatelet, antineutrophil and vasodilating properties of 13,14-dihydro-PGE1 (PGE0)--an in vivo metabolite of PGE1 in man. Eicosanoids, 1991, Volume: 4, Issue:3 Topics: Alprostadil; Animals; Blood Platelets; Glucuronidase; Humans; In Vitro Techniques; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Platelet Activating Factor; Rabbits; Superoxides; Vasodilation	1991
The effect of lipo-prostaglandin E1 on the production of interleukin 1 and platelet-activating factor by hepatic sinusoidal endothelial cells in mice. Osaka city medical journal, 1991, Volume: 37, Issue:2 Topics: Alprostadil; Animals; Endothelium; Interleukin-1; Liver; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Platelet Activating Factor	1991
Activation of protein kinase C inhibits hormonal stimulation of the GTPase activity of Gi in human platelets. FEBS letters, 1991, Feb-25, Volume: 279, Issue:2 Topics: Adenosine Diphosphate Ribose; Alprostadil; Blood Platelets; Enzyme Activation; Epinephrine; GTP Phosphohydrolases; GTP-Binding Proteins; Humans; Pertussis Toxin; Platelet Activating Factor; Protein Kinase C; Tetradecanoylphorbol Acetate; Thrombin; Virulence Factors, Bordetella	1991
PAF-induced bowel necrosis. Effects of vasodilators. Digestive diseases and sciences, 1991, Volume: 36, Issue:5 Topics: Alprostadil; Animals; Hydralazine; Hypotension; Indazoles; Intestinal Diseases; Leukopenia; Male; Mesenteric Arteries; Necrosis; Nitroglycerin; Phenoxybenzamine; Platelet Activating Factor; Prazosin; Rats; Rats, Inbred Strains; SRS-A; Vasodilator Agents	1991
The adhesiveness of monocytic U937 cells is stimulated by pro-inflammatory agents and inhibited by adenosine 3':5'-cyclic monophosphate. Biochemical pharmacology, 1990, Feb-15, Volume: 39, Issue:4 Topics: 2-Chloroadenosine; 8-Bromo Cyclic Adenosine Monophosphate; Adenosine; Alprostadil; Bucladesine; Calcitriol; Cell Adhesion; Cell Differentiation; Cell Line; Cyclic AMP; Diglycerides; Humans; Kinetics; Leukotriene B4; Monocytes; N-Formylmethionine Leucyl-Phenylalanine; Platelet Activating Factor; Tretinoin	1990
Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP. Molecular pharmacology, 1990, Volume: 37, Issue:5 Topics: Adenosine; Adenylyl Cyclases; Alprostadil; Animals; Blood Platelets; Cyclic AMP; Cyclic GMP; Enzyme Activation; Ferricyanides; Hemoglobins; In Vitro Techniques; Kinetics; Molsidomine; Nitroprusside; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Quinolones; Rabbits; Radioimmunoassay; Vasodilator Agents	1990
Effect of CV-3988, a specific antagonist against platelet activating factor, on homologous passive cutaneous anaphylaxis in the mouse ear. Journal of pharmacobio-dynamics, 1990, Volume: 13, Issue:5 Topics: Alprostadil; Animals; Antibodies; Blood Vessels; Dinoprostone; Ear, External; Female; Histamine; Immunoglobulin E; Immunoglobulin G; Leukotriene E4; Mice; Mice, Inbred BALB C; Passive Cutaneous Anaphylaxis; Permeability; Phospholipid Ethers; Platelet Activating Factor; Serotonin; Skin; SRS-A	1990
Evidence for the receptor-operated calcium channels in human platelet plasma membrane. Thrombosis research, 1987, Apr-01, Volume: 46, Issue:1 Topics: Alprostadil; Aminoquinolines; Barium; Biological Transport; Blood Platelets; Calcium; Cell Membrane; Humans; In Vitro Techniques; Ion Channels; Platelet Activating Factor; Receptors, Cell Surface; Tetradecanoylphorbol Acetate	1987
Potent inhibition of PAF-stimulated human platelets and polymorphonuclear leukocytes by the PGE1 analog OP-1206. Progress in clinical and biological research, 1987, Volume: 242 Topics: Alprostadil; Blood Platelets; Epoprostenol; Humans; Iloprost; Kinetics; Neutrophils; Platelet Activating Factor; Platelet Aggregation	1987
Protective effects of a platelet activating factor (PAF) antagonist and its combined treatment with prostaglandin (PG) E1 in traumatic shock. Journal of cardiovascular pharmacology, 1988, Volume: 12, Issue:5 Topics: Alprostadil; Animals; Blood Pressure; Cathepsin D; Drug Therapy, Combination; Male; Myocardial Depressant Factor; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Inbred Strains; Shock, Traumatic; Time Factors	1988
Potent inhibition of leukotriene (LT) B4 release from human polymorphonuclear leukocytes (PMN) by the PGE1-analogue OP-1206. Biomedica biochimica acta, 1988, Volume: 47, Issue:10-11 Topics: Alprostadil; Dinoprostone; Epoprostenol; Humans; Iloprost; In Vitro Techniques; Leukotriene B4; Neutrophils; Platelet Activating Factor; Prostaglandins E, Synthetic	1988
Vasodepression ex vivo after administration of inflammatory mediators in vivo in the rat. Agents and actions, 1989, Volume: 28, Issue:1-2 Topics: Alprostadil; Animals; Biological Factors; Bradykinin; Endotoxins; Epoprostenol; Escherichia coli; Female; Histamine; Inflammation; Norepinephrine; p-Methoxy-N-methylphenethylamine; Platelet Activating Factor; Rats; Serotonin; SRS-A; Substance P; Vasoconstriction	1989
Lipid mediator production by post-implantation rat embryos in vitro. Prostaglandins, 1989, Volume: 38, Issue:2 Topics: Alprostadil; Animals; Cells, Cultured; Dinoprostone; Embryo, Mammalian; Embryonic Development; Female; Gestational Age; Leukotrienes; Lipid Metabolism; Platelet Activating Factor; Pregnancy; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Rats; Rats, Inbred Strains; Thromboxane B2	1989
[Kinetics of the cellular response: the phenomenon of supercooperativity in platelet aggregation]. Doklady Akademii nauk SSSR, 1989, Volume: 307, Issue:2 Topics: Adenosine Diphosphate; Alprostadil; Arachidonic Acid; Arachidonic Acids; Epinephrine; Humans; In Vitro Techniques; Indomethacin; Kinetics; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors	1989
Lack of effect of opioid peptides, morphine and naloxone on superoxide formation in human neutrophils and HL-60 leukemic cells. Naunyn-Schmiedeberg's archives of pharmacology, 1989, Volume: 340, Issue:1 Topics: Adenosine Triphosphate; Alprostadil; Biotransformation; Endorphins; Enkephalin, Methionine; Humans; In Vitro Techniques; Leukemia, Experimental; Morphine; N-Formylmethionine Leucyl-Phenylalanine; Naloxone; Neutrophils; Oxygen Consumption; Platelet Activating Factor; Superoxides; Tumor Cells, Cultured	1989
The relevance of eicosanoids including PAF for the biochemical regulation of cardiac rhythm. Progress in clinical and biological research, 1989, Volume: 301 Topics: Alprostadil; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Azepines; Diterpenes; Dogs; Fatty Acids, Unsaturated; Female; Ginkgolides; Guinea Pigs; Heart Rate; In Vitro Techniques; Lactones; Male; Platelet Activating Factor; Sulfonamides; Triazines; Triazoles	1989
Platelet activating factor-mediated leukotriene biosynthesis in rat lungs: effect of prostaglandins E1 and F1 alpha. Biochemical and biophysical research communications, 1987, Sep-30, Volume: 147, Issue:3 Topics: Alprostadil; Animals; Chromatography, High Pressure Liquid; Cyclic AMP; In Vitro Techniques; Leukotriene E4; Lung; Platelet Activating Factor; Prostaglandins F; Radioimmunoassay; Rats; SRS-A	1987
Hispidulin, a natural flavone, inhibits human platelet aggregation by increasing cAMP levels. European journal of pharmacology, 1988, Feb-16, Volume: 147, Issue:1 Topics: Alprostadil; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Buffers; Collagen; Cyclic AMP; Flavones; Flavonoids; Humans; In Vitro Techniques; Platelet Activating Factor; Platelet Aggregation Inhibitors; Radioimmunoassay; Theophylline	1988
Protective action of prostaglandin E1 (PGE1) against constrictor mediators in isolated rat heart and lung. Biochemical pharmacology, 1988, Jul-01, Volume: 37, Issue:13 Topics: Alprostadil; Animals; Arginine Vasopressin; Coronary Circulation; Cyclic AMP; Nitroprusside; Perfusion; Platelet Activating Factor; Prostaglandins; Pulmonary Circulation; Rats; Vascular Resistance	1988
Specific binding of platelet-activating factor (PAF) by human peripheral blood mononuclear leukocytes. Biochemical and biophysical research communications, 1988, Aug-30, Volume: 155, Issue:1 Topics: Alprostadil; Binding, Competitive; Furans; Humans; Kinetics; Leukocytes, Mononuclear; N-Formylmethionine Leucyl-Phenylalanine; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled	1988
The influence of activating hormones on human platelet membrane Ca2+-ATPase activity. Biochemical and biophysical research communications, 1986, Jul-16, Volume: 138, Issue:1 Topics: Adenosine Diphosphate; Alprostadil; Blood Platelets; Calcimycin; Calcium-Transporting ATPases; Cell Membrane; Colforsin; Ethers; Humans; Ionomycin; Kinetics; Platelet Activating Factor; Tetradecanoylphorbol Acetate; Thrombin; Vasopressins	1986
Tumor differentiation--application of prostaglandins in the treatment of neuroblastoma. Progress in clinical and biological research, 1985, Volume: 175 Topics: Abdominal Neoplasms; Alprostadil; Animals; Blood Coagulation Factors; Cell Differentiation; Cell Division; Cells, Cultured; Child; Child, Preschool; Cyclic AMP; Drug Evaluation; Drug Evaluation, Preclinical; Drug Therapy, Combination; Female; Humans; Male; Mice; Neuroblastoma; Papaverine; Platelet Activating Factor; Prostaglandin D2; Prostaglandins D; Prostaglandins E	1985
Phosphatidate and monooleylphosphatidate inhibition of fibroblast adenylate cyclase is mediated by the inhibitory coupling protein, Ni. Molecular pharmacology, 1985, Volume: 28, Issue:4 Topics: Adenosine Diphosphate Ribose; Adenylate Cyclase Toxin; Adenylyl Cyclase Inhibitors; Alprostadil; Carbachol; Cell Line; Cell Membrane; Cyclic AMP; Diglycerides; GTP-Binding Proteins; Humans; Lysophospholipids; Magnesium; Pertussis Toxin; Phosphatidic Acids; Phosphatidylcholines; Phosphatidylinositols; Platelet Activating Factor; Virulence Factors, Bordetella	1985
[Mechanism of increase in Ca2+ level in platelet cytoplasm induced by aggregating factors]. Biokhimiia (Moscow, Russia), 1985, Volume: 50, Issue:8 Topics: Alprostadil; Blood Coagulation Factors; Blood Platelets; Calcium; Cyclic AMP; Cytoplasm; Fluorescent Dyes; Humans; In Vitro Techniques; Platelet Activating Factor; Verapamil	1985
Platelet-activating factor-induced ischemic bowel necrosis. An investigation of secondary mediators in its pathogenesis. The American journal of pathology, 1986, Volume: 122, Issue:2 Topics: Alprostadil; Animals; Blood Pressure; Catechols; Chromones; Diethylcarbamazine; Disease Models, Animal; Hematocrit; Indomethacin; Intestines; Ischemia; Leukocyte Count; Lipopolysaccharides; Lipoxygenase Inhibitors; Male; Masoprocol; Methacrylates; Necrosis; Platelet Activating Factor; Rats; Rats, Inbred Strains; Salmonella typhi; Thromboxane-A Synthase; Verapamil	1986
Cationized ferritin as a platelet-stimulating surface probe. Binding to platelets and effects on platelet function. European journal of cell biology, 1986, Volume: 40, Issue:1 Topics: Agglutination; Alprostadil; Binding Sites; Blood Platelets; Dose-Response Relationship, Drug; Edetic Acid; Ferritins; Humans; Indomethacin; Neuraminidase; Plasma; Platelet Activating Factor; Platelet Aggregation; Serotonin; Tritium	1986
Prolongation of pig-to-dog renal xenograft survival by modification of the inflammatory mediator response. Annals of surgery, 1987, Volume: 206, Issue:4 Topics: Alprostadil; Animals; Biopsy; Dogs; Epoprostenol; Female; Graft Survival; Inflammation; Kidney; Kidney Transplantation; Male; Platelet Activating Factor; Platelet Count; Quinolinium Compounds; Renal Circulation; Swine; Transplantation, Heterologous	1987
Polymorphonuclear leukocyte-dependent plasma leakage in the rabbit skin is enhanced or inhibited by prostacyclin, depending on the route of administration. The American journal of pathology, 1986, Volume: 124, Issue:1 Topics: Alprostadil; Animals; Bradykinin; Complement C5; Complement C5a, des-Arginine; Drug Synergism; Edema; Epoprostenol; Infusions, Parenteral; Injections, Intradermal; Male; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Plasma Volume; Platelet Activating Factor; Rabbits; Skin Diseases	1986
Phorbol esters sensitize platelets to activation by physiological agonists. Blood, 1987, Volume: 70, Issue:5 Topics: Adenosine Diphosphate; Alprostadil; Collagen; Humans; Kinetics; Phorbol Esters; Platelet Activating Factor; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Structure-Activity Relationship; Vasopressins	1987
Action mechanism of the platelet aggregation inducer and inhibitor from Echis carinatus snake venom. Biochimica et biophysica acta, 1985, Jul-26, Volume: 841, Issue:1 Topics: Adenosine Diphosphate; Alprostadil; Animals; Arachidonic Acid; Arachidonic Acids; Calcimycin; Chymotrypsin; Collagen; Fibrinogen; Heparin; Hirudins; Platelet Activating Factor; Platelet Aggregation; Prostaglandins E; Rabbits; Thrombin; Viper Venoms	1985
The effect of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (paf-acether) on the arterial wall. Prostaglandins, 1985, Volume: 30, Issue:2 Topics: Adenosine Diphosphate; Alprostadil; Animals; Arteries; Diterpenes; Edetic Acid; Epoprostenol; Ginkgolides; Guinea Pigs; In Vitro Techniques; Lactones; Male; Microscopy, Electron; Microscopy, Electron, Scanning; Plant Extracts; Platelet Activating Factor; Platelet Aggregation; Quinacrine; Thrombosis	1985
Influence of platelet activation factor and prostaglandins on cholesterol esterification in human plasma. FEBS letters, 1985, Oct-14, Volume: 190, Issue:2 Topics: Alprostadil; Cholesterol Esters; Humans; Lipoproteins; Platelet Activating Factor; Prostaglandins	1985
Inhibition of platelet adenylate cyclase by 1-O-alkyl-2-O-acetyl-sn-glyceryl-3-phosphorylcholine (platelet-activating factor). The Journal of biological chemistry, 1982, Jun-25, Volume: 257, Issue:12 Topics: 1-Methyl-3-isobutylxanthine; Adenosine Diphosphate; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Alprostadil; Animals; Blood Platelets; Creatine Kinase; Cyclic AMP; Indomethacin; Lysophosphatidylcholines; Phosphocreatine; Platelet Activating Factor; Prostaglandins E; Rabbits	1982
Effects of a thio analog of platelet-activating factor on platelet aggregation and adenosine 3',5'-monophosphate concentration in hepatocyte suspensions and in platelets. A comparison with the naturally occurring compound. Hoppe-Seyler's Zeitschrift fur physiologische Chemie, 1984, Volume: 365, Issue:1 Topics: Alprostadil; Animals; Blood Platelets; Cyclic AMP; Humans; In Vitro Techniques; Indomethacin; L-Lactate Dehydrogenase; Liver; Male; Platelet Activating Factor; Platelet Aggregation; Prostaglandins E; Rats; Rats, Inbred Strains; Time Factors	1984
CV-3988 - a specific antagonist of platelet activating factor (PAF). Life sciences, 1983, Apr-25, Volume: 32, Issue:17 Topics: Adenosine Diphosphate; Alprostadil; Animals; Arachidonic Acid; Arachidonic Acids; Blood Pressure; Calcimycin; Collagen; Dose-Response Relationship, Drug; Male; Micelles; Phospholipid Ethers; Platelet Activating Factor; Platelet Aggregation; Prostaglandins E; Rabbits; Rats; Rats, Inbred Strains; Thiazoles	1983
On the nature of the vasoreactivity depressing factor (VDF) in inflammation and anaphylaxis in the rat and mouse. Biomedica biochimica acta, 1984, Volume: 43, Issue:8-9 Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Alprostadil; Anaphylaxis; Animals; Anti-Inflammatory Agents; Epoprostenol; Female; Histamine; Indomethacin; Inflammation; Male; Mice; Mice, Inbred Strains; Norepinephrine; Platelet Activating Factor; Prostaglandins E; Pyrazoles; Rats; Rats, Inbred Strains; Serotonin; Vasopressins	1984
[Incorporation of 1-0-alkyl-2-acetyl-sn-glycerol-3-phosphocholine into human plasma lipoproteins in vitro. Effect of the lecithin:cholesterol acyltransferase activity of plasma]. Biokhimiia (Moscow, Russia), 1984, Volume: 49, Issue:9 Topics: Alprostadil; Binding, Competitive; Cholesterol; Esterification; Humans; In Vitro Techniques; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Phosphatidylcholine-Sterol O-Acyltransferase; Platelet Activating Factor; Prostaglandins E; Protein Binding	1984
Inflammatory actions of platelet activating factor (Pafacether) in guinea-pig skin. British journal of pharmacology, 1983, Volume: 80, Issue:3 Topics: Alprostadil; Animals; Blood Proteins; Erythrocyte Aggregation; Guinea Pigs; Inflammation; Male; Platelet Activating Factor; Platelet Aggregation; Prostaglandins E; Skin	1983
E-type prostaglandins enhance local oedema formation and neutrophil accumulation but suppress eosinophil accumulation in guinea-pig skin. British journal of pharmacology, 1993, Volume: 110, Issue:1 Topics: Alprostadil; Animals; Dinoprostone; Edema; Eosinophils; Guinea Pigs; Iloprost; In Vitro Techniques; Indium Radioisotopes; Isoproterenol; Male; Neutrophils; Passive Cutaneous Anaphylaxis; Platelet Activating Factor; Prostaglandins E; Skin; Zymosan	1993
Anti-inflammatory effect of prostanoids in mouse and rat skin: evidence for a role of EP3-receptors. The Journal of pharmacology and experimental therapeutics, 1994, Volume: 268, Issue:3 Topics: Alprostadil; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood; Dinoprostone; Edema; Male; Mice; Misoprostol; Platelet Activating Factor; Rats; Rats, Wistar; Receptors, Prostaglandin E; Skin; Zymosan	1994
Rabbit lung macrophages stimulate platelets in vitro as observed by density-gradient centrifugation and transmission electron microscopy. Scandinavian journal of clinical and laboratory investigation, 1993, Volume: 53, Issue:7 Topics: Adenosine Diphosphate; Alprostadil; Animals; Cell Communication; Cells, Cultured; Centrifugation, Density Gradient; Creatine Kinase; Edetic Acid; Ferric Compounds; Macrophages, Alveolar; Microscopy, Electron; Phosphocreatine; Platelet Activating Factor; Platelet Activation; Rabbits; Thrombin; Triazolam	1993
Elevated intracellular cyclic AMP inhibits chemotaxis in human eosinophils. Cellular signalling, 1995, Volume: 7, Issue:5 Topics: Alprostadil; Chemotaxis, Leukocyte; Colforsin; Complement C5a; Cyclic AMP; Eosinophils; Humans; Phosphodiesterase Inhibitors; Platelet Activating Factor; Quinazolines	1995
Role of platelet-activating factor in Chinese hamster ovary cell responses to cholera toxin. The Journal of clinical investigation, 1997, Apr-15, Volume: 99, Issue:8 Topics: Alprostadil; Animals; Bucladesine; Cell Size; CHO Cells; Cholera Toxin; Cricetinae; Cyclic AMP; Cycloheximide; Dactinomycin; Dinoprostone; Diterpenes; Ginkgolides; Humans; Lactones; Phospholipases A; Platelet Activating Factor; Platelet Membrane Glycoproteins; Protein Synthesis Inhibitors; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Thiazoles	1997
Characterization of the prostanoid receptors mediating inhibition of PAF-induced aggregation of guinea-pig eosinophils. British journal of pharmacology, 1997, Volume: 121, Issue:1 Topics: Alprostadil; Analysis of Variance; Animals; Anti-Ulcer Agents; Carbazoles; Cell Aggregation; Dinoprostone; Dose-Response Relationship, Drug; Eosinophils; Female; Guinea Pigs; Indoles; Misoprostol; Oxytocics; Platelet Activating Factor; Platelet Aggregation Inhibitors; Prostaglandin D2; Prostaglandins E, Synthetic; Prostanoic Acids; Protein Kinase C; Pyrroles; Receptors, Prostaglandin; Structure-Activity Relationship	1997
Mechanisms of interaction of a plasmalogenic analog of platelet-activating factor with human platelets. Biochemistry. Biokhimiia, 1999, Volume: 64, Issue:6 Topics: Adenylyl Cyclase Inhibitors; Alprostadil; Azepines; Blood Platelets; Calcium; Dose-Response Relationship, Drug; Humans; Kinetics; Plasmalogens; Platelet Activating Factor; Triazoles	1999
Effect of inflammatory mediators on the electrophysiology of the human oviduct. Biology of reproduction, 1999, Volume: 61, Issue:3 Topics: Alprostadil; Calcium; Cells, Cultured; Chlorides; Dinoprostone; Electric Conductivity; Electrophysiology; Epithelial Cells; Fallopian Tubes; Female; Histamine; Histamine Antagonists; Histamine H1 Antagonists; Histamine H2 Antagonists; Humans; Ion Channels; Leukotriene B4; Membrane Potentials; Piperidines; Platelet Activating Factor	1999
The role of inflammatory mediators in the mechanism of the host immune response induced by ischemia-reperfusion injury. Immunological investigations, 2000, Volume: 29, Issue:1 Topics: Alprostadil; Animals; Female; Histocompatibility Antigens Class II; Inflammation Mediators; Infusions, Intravenous; Isoquinolines; Platelet Activating Factor; Pyridinium Compounds; Regression Analysis; Reperfusion Injury; Swine; T-Lymphocyte Subsets; Tetrahydroisoquinolines; Up-Regulation	2000
Bioactive amide of prostaglandin E1 and ethanolamine plasmalogen analog of platelet-activating factor inhibits several pathways of human platelet aggregation. Biochemistry. Biokhimiia, 2000, Volume: 65, Issue:4 Topics: Alprostadil; Amides; Blood Platelets; Dose-Response Relationship, Drug; Humans; Phosphatidylethanolamines; Plasmalogens; Platelet Activating Factor; Platelet Aggregation; Thrombin	2000
Inhibition of induced and spontaneous platelet aggregation by destabilase from medicinal leech. Platelets, 2000, Volume: 11, Issue:2 Topics: Adenosine Diphosphate; Adenylyl Cyclases; Alprostadil; Animals; Blood Platelets; Cardiovascular Diseases; Collagen; Dose-Response Relationship, Drug; Endopeptidases; Fibrinolytic Agents; Humans; Leeches; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors	2000
The role of prostanoid receptors in mediating the effects of PGE3 on human platelet function. Thrombosis and haemostasis, 2012, Volume: 107, Issue:4 Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Alprostadil; Atherosclerosis; Blood Platelets; Cardiovascular System; Dose-Response Relationship, Drug; Humans; P-Selectin; Platelet Activating Factor; Platelet Aggregation; Receptors, Prostaglandin E	2012